Top Medical News
8 hours ago
Mirabegron, a β3-adrenoreceptor agonist, poses no increased cardiovascular risk when used as treatment for overactive bladder syndrome, a new study has found.
2 days ago
A recent study has confirmed that weight gain increases the risk of progression of lower urinary tract symptom (LUTS) in middle-aged and elderly men. However, metabolic syndrome factors such as history of type 2 diabetes and hypertension are not associated with progression, contrary to previous reports.
4 days ago
The combination of lidocaine and diclofenac is superior to lidocaine alone at reducing pain during benign anorectal surgery, a recent study has shown.
03 Dec 2018
Men undergoing active surveillance for prostate cancer exhibit moderate risk of cancer-specific mortality, which significantly declines over time, a recent study reports.
30 Nov 2018
It appears that four cycles of platinum-based, first-line chemotherapy are tolerable and do not significantly compromise the survival of patients with metastatic urothelial carcinoma, suggests a study.
28 Nov 2018
Use of clomipramine as an on-demand treatment of premature ejaculation is well tolerated and effective, with the results of a phase III study showing increased ejaculation time during vaginal penetration.
Christina Lau, 28 Nov 2018

Stereotactic body radiotherapy (SBRT) is associated with significantly lower rates of acute gastrointestinal (GI) and genitourinary (GU) toxicities compared with conventional fractionated intensity-modulated radiotherapy (CF-IMRT) in Asian patients with early-stage localized prostate cancer.

Special Reports
Dr. Joe Lee, 12 Apr 2018

A 70-year-old male with a history of diabetes, hyperlipidaemia and hypertension managed with atenolol presented to his family physician with lower urinary tract symptoms (LUTS). He was prescribed terazosin. Over the course of a year he noticed worsening erectile dysfunction (ED) with difficulty maintaining a hard erection until orgasm.

Dr. Devdatt Palnitkar, 16 Mar 2018
Dr Devdatt Palnitkar of the Palnitkar Hospital, Aurangabad, India, shared a practical guide to treating mild to moderate Overactive bladder (OAB).
02 Nov 2017
Nocturia is the most prevalent of the lower urinary tract symptoms (LUTS) and can cause a significant negative impact on an individual’s quality of life if left untreated.1,2 In a meeting held at University Malaya Medical Centre, Associate Professor Dr Ong Teng Aik shared his insights on the management of nocturia.
15 Jun 2017
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
Roshini Claire Anthony, 25 Apr 2016

Elderly patients on androgen deprivation therapy (ADT) as part of prostate cancer treatment may be at an increased risk of depression, a recent study states.

Roshini Claire Anthony, 24 Mar 2016

Salvage radical prostatectomy (SRP) after radiation produces good long-term survival rates in men with prostate adenocarcinoma, according to a recent study.

Conference Reports
Audrey Abella, 11 May 2018
Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.
Audrey Abella, 30 Apr 2018
The selective β3-adrenoreceptor (AR) agonist vibegron showed superior efficacy over placebo for overactive bladder (OAB) treatment and was generally well-tolerated, according to a Japanese study presented at EAU 2018.

Roshini Claire Anthony, 23 Apr 2018

Targeted antibiotic prophylaxis – after a rectal swab to identify specific intestinal flora – does not appear to significantly impact the risk of urinary sepsis following a transrectal ultrasound (TRUS)-guided prostate biopsy, according to a recent study.

Roshini Claire Anthony, 20 Apr 2018

Conservative management appears to be the favoured option in managing non-penetrating renal trauma with urinary extravasation, according to a study presented at EAU 2018.

Christina Lau, 16 Apr 2018

MRI, with or without targeted biopsy, detects more clinically significant prostate cancer and less clinically insignificant prostate cancer than the standard transrectal ultrasonography (TRUS)-guided approach, enabling more than one-quarter of patients to safely avoid a biopsy altogether.

Christina Lau, 12 Apr 2018

Men with nonmetastatic castration-resistant prostate cancer (CRPC) have similar health-related quality of life (HRQoL) with apalutamide given on top of androgen deprivation therapy (ADT) vs ADT alone, according to new data from the SPARTAN (Prostate Androgen Receptor Targeting with ARN-509) trial presented at the European Association of Urology (EAU) 2018 Congress.

Christina Lau, 02 Apr 2018

Patients with urologic cancers are more likely to attempt suicide, highlighting the need for increased psychiatric intervention for these patients at an earlier stage, according to findings presented at the European Association of Urology (EAU) 2018 Congress.